Lyell Immunopharma, Inc. (LYEL)

NASDAQ

$8.27

$-0.47

(-5.40%)

Pre-Market

Lyell Immunopharma, Inc. (LYEL) Live Price Chart

Last updated: ⁦2026-10-13 09:18:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Lyell Immunopharma, Inc. (LYEL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $8.27, with a market capitalisation of $213.44M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.21 to $45.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$213.44M
Open	$8.63
Day's High	$396.80
Day's Low	$7.65
Previous Close	$8.71
Volume	89.28K
Average Volume	144.65K
P/E Ratio	--
52-Week High	$45.00
52-Week Low	$8.21
Dividend Yield	--
Earnings Date	--

Lyell Immunopharma, Inc. (LYEL) Pre-Market Stock Price

Lyell Immunopharma, Inc. (LYEL) is trading at $8.91 in pre-market trading as of 2026-10-12 21:39:00, up 2.34% ($0.20) from the previous close of $8.71

Pre-market trading shows how investors are pricing LYEL before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Lyell Immunopharma, Inc. (LYEL) 7-Day Stock Price Change

Over the past seven days, Lyell Immunopharma, Inc. (LYEL) moved from $9.26 to $8.27, representing a decline of 10.69% ($0.99).

The stock traded between $8.21 and $9.56 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 136.07 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

LYEL 52-Week Price Position

Position in Range: 0.2%

52W Low$8.21

52W High$45.00

LYEL is currently trading at $8.27, placing it 0.2% of the way from its 52-week low of $8.21 to its 52-week high of $45.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lyell Immunopharma, Inc. (LYEL)?

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

Lyell Immunopharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	161
Exchange	NASDAQ
Company Website	https://www.lyell.com

How to Buy Lyell Immunopharma, Inc. (LYEL) Stock on MEXC

Eligible investors can buy real shares of Lyell Immunopharma, Inc. (LYEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LYEL and Place Your Order

Open the RealStocks trading page and search for LYEL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lyell Immunopharma, Inc. (LYEL) stock price today?

Lyell Immunopharma, Inc. (LYEL) is currently trading at $ 8.27, down 5.05% ($0.44) from the previous close of $ 8.71. Intraday prices update in real time during regular trading hours.

2.Is LYEL stock going up or down today?

As of 2026-10-12 21:39:00, LYEL is trading at $ 8.27, down 5.05% ($0.44) from its previous close of $ 8.71. The stock has traded between $ 7.65 and $ 396.80 during today’s regular session. Past price movements do not guarantee future results.

3.What is LYEL pre-market price?

As of 2026-10-12 21:39:00, LYEL is trading at $ 8.91 in pre-market trading, up 2.34% ($0.20) from the previous close of $ 8.71. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LYEL after-hours price?

As of 2026-10-12 21:39:00, LYEL is trading at $ 8.27 in after-hours trading, down 5.05% ($0.44) from the regular-session close of $ 8.71. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LYEL stock trading now?

LYEL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LYEL sit relative to its 52-week high and low?

Over the past 52 weeks, LYEL has traded between a low of $ 8.21 and a high of $ 45.00. At $ 8.27, the stock is positioned 0.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lyell Immunopharma, Inc. in?

Lyell Immunopharma, Inc. (LYEL) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lyell Immunopharma, Inc.'s market capitalisation and where is it listed?

Lyell Immunopharma, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 213.44M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LYEL valued in terms of P/E ratio and EPS?

LYEL trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -10.14. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lyell Immunopharma, Inc. pay a dividend?

Lyell Immunopharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.